Cargando…
In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats
Background and purpose: We have shown that in vitro treatment with cannabidiol (CBD, 2 h) enhances endothelial function in arteries from Zucker diabetic fatty (ZDF) rats, partly due to a cyclooxygenase (COX)-mediated mechanism. The aim of the present study was to determine whether treatment with CBD...
Autores principales: | Wheal, Amanda J., Jadoon, Khalid, Randall, Michael D., O’Sullivan, Saoirse E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436470/ https://www.ncbi.nlm.nih.gov/pubmed/28572770 http://dx.doi.org/10.3389/fphar.2017.00248 |
Ejemplares similares
-
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB(1) activation
por: Stanley, Christopher P., et al.
Publicado: (2015) -
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries
por: Stanley, Christopher P., et al.
Publicado: (2016) -
Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries
por: Stanley, Christopher P., et al.
Publicado: (2014) -
Impaired dopamine D(1) receptor-mediated vasorelaxation of mesenteric arteries in obese Zucker rats
por: Fu, Jinjuan, et al.
Publicado: (2014) -
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
por: Millar, Sophie A., et al.
Publicado: (2018)